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Ethnic distinctions in the pathophysiology of type 2 diabetes: a focus on
black African-Caribbean populations
Louise M. Goff* , Meera Ladwa, Olah Hakim and Oluwatoyosi Bello
Diabetes Research Group, Departments of Diabetes and Nutritional Sciences, King’s College London, London, UK
Type 2 diabetes (T2D) is a global public health priority, particularly for populations of black
African-Caribbean ethnicity, who suffer disproportionately high rates of the disease. While
the mechanisms underlying the development of T2D are well documented, there is growing
evidence describing distinctions among black African-Caribbean populations. In the present
paper, we review the evidence describing the impact of black African-Caribbean ethnicity on
T2D pathophysiology. Ethnic differences were ﬁrst recognised through evidence that meta-
bolic syndrome diagnostic criteria fail to detect T2D risk in black populations due to less
central obesity and dyslipidaemia. Subsequently more detailed investigations have recog-
nised other mechanistic differences, particularly lower visceral and hepatic fat accumulation
and a distinctly hyperinsulinaemic response to glucose stimulation. While epidemiological
studies have reported exaggerated insulin resistance in black populations, more detailed
and direct measures of insulin sensitivity have provided evidence that insulin sensitivity is
not markedly different to other ethnic groups and does not explain the hyperinsulinaemia
that is exhibited. These ﬁndings lead us to hypothesise that ectopic fat does not play a pivotal
role in driving insulin resistance in black populations. Furthermore, we hypothesise that
hyperinsulinaemia is driven by lower rates of hepatic insulin clearance rather than heigh-
tened insulin resistance and is a primary defect rather than occurring in compensation for
insulin resistance. These hypotheses are being investigated in our ongoing South London
Diabetes and Ethnicity Phenotyping study, which will enable a more detailed understanding
of ethnic distinctions in the pathophysiology of T2D between men of black African and
white European ethnicity.
Ethnicity: African: Type 2 diabetes: Insulin sensitivity: β-cell function
Ethnic inequalities in type 2 diabetes in the UK
It is estimated that one in eleven adults worldwide is liv-
ing with diabetes; this equates to 425 million people, a
ﬁgure which is predicted to rise to 629 million by
2045(1). The alarming rate at which diabetes is increasing
makes it a global public health priority. In the UK, 3·7
million people have diagnosed diabetes, although the
actual prevalence is thought to be nearer to 5 million
when undiagnosed cases are considered(2). Ethnic
inequalities in diabetes have been reported consistently
in the scientiﬁc literature. The present paper will focus
speciﬁcally on type 2 diabetes (T2D) as it is the burden
of this disease that is most evident among ethnic minority
groups.
In 2011, approximately 14 % of the UK population
identiﬁed as from a minority ethnic background; about
half were of South Asian ancestry (originating mainly
from India, Pakistan, Bangladesh and Sri Lanka), and
approximately 25 % were of black, African, Caribbean
*Corresponding author: Louise M. Goff, email louise.goff@kcl.ac.uk
Abbreviations: IHL, intrahepatic lipid; IPL, intrapancreatic lipid; SAT, subcutaneous adipose tissue; T2D, type 2 diabetes; VAT, visceral adipose
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or other black ancestry(3). Among ethnic minority
groups, the prevalence of T2D is estimated to be about
three to ﬁve times higher than in people of white
European ethnicity(4). The London SABRE multi-ethnic
cohort estimated that by age 80 years, 40–50 % of South
Asian and black African-Caribbean men and women will
have T2D, which is at least twice the proportion of their
age-matched white European counterparts(5). An earlier
onset of T2D is also particularly noticeable. A recent
analysis of UK primary care data showed the age of
diagnosis to be 10–12 years younger, on average, in
South Asians and black African-Caribbeans compared
to white Europeans(6). Moreover, a signiﬁcantly greater
proportion of people from ethnic minority backgrounds
develop T2D before age 40 years compared to
white-Europeans: 30 % of South Asians and 23 % of
black African-Caribbeans with T2D are under age 40
years compared to only 9 % of white Europeans
(Fig. 1)(6).
Following the recognition that 90 % of adults with
T2D are overweight or obese, and T2D is ﬁve times
more prevalent amongst adults with an obese BMI com-
pared to those with a healthy weight(7), obesity is now
recognised to be one of the strongest contributors to
the development of T2D. In the UK, about 60 % of
adults are overweight or obese (BMI ≥25 kg/m2) and
25 % are obese (BMI ≥30 kg/m2)(8). In some ethnic
groups, obesity rates are high, for example, black
African-Caribbean and Pakistani women, but in others
(e.g. black African-Caribbean, Indian, Pakistani and
Bangladeshi men), the rates are no different from white
Europeans or the general population(4). This pattern of
obesity being more common among ethnic minority
populations and particularly among ethnic minority
females is replicated in America, in which African-
American and Hispanic women suffer the highest rates
of obesity(9–11). The reasons for these ethnic and sex dis-
parities are complex and not fully understood but are
believed to involve both biological and environmental
factors(12). Recently several UK multi-ethnic cohort stud-
ies have identiﬁed a higher risk of T2D at lower levels of
obesity among ethnic minority groups compared with
white Europeans(6,13,14). Modelling of UK Biobank
data has demonstrated that the T2D risk associated
with a BMI of 30 kg/m2 in white Europeans is equivalent
to a BMI of 22 kg/m2 in South Asian groups and a BMI
of 26 kg/m2 in black African-Caribbean groups(13). Data
from The Health Improvement Network, a UK longitu-
dinal general practice dataset, demonstrate that 38 % of
South Asians and 29 % of black African-Caribbeans
with T2D have a BMI below 30 kg/m2 compared to
only 26 % of white Europeans. Furthermore, both
South Asians and black African-Caribbeans have a sign-
iﬁcantly higher probability of developing T2D in the nor-
mal and overweight BMI categories compared to white
Europeans(6). This evidence suggests that the commonly
used clinical deﬁnitions for obesity, that are derived
from populations of white European descent (BMI
≥30 kg/m2; waist circumference ≥88 cm in women and
≥102 cm in men), may not be appropriate for screening
diabetes risk in non-white groups. Accordingly, the
WHO and International Diabetes Federation have pro-
posed that overweight is deﬁned as BMI >23 kg/m2,
and obesity >27·5 kg/m2, in Asian adults, with waist cir-
cumference cut-offs of 80 cm for Asian women and 90
cm for Asian men(15,16), although there is pressure for
lower cut-offs to be introduced(17). Currently there are
no agreed speciﬁc cut-offs for men and women of black
African-Caribbean ethnicity and European thresholds
remain in use for these populations.
The development of diabetes often manifests itself,
clinically, as the metabolic syndrome. First described in
the 1980s, the metabolic syndrome is a clustering of
metabolic abnormalities, namely abdominal obesity,
hypertension, dyslipidaemia (low HDL-cholesterol and
high TAG concentrations) and hyperglycaemia, which
are associated with insulin resistance and commonly pre-
cede the onset of T2D(18). In 2006, the International
Diabetes Federation published a consensus worldwide
deﬁnition to aid detection of metabolic syndrome(16).
Using these criteria, it is estimated that about 22 % of
adults have the metabolic syndrome and will go on to
develop T2D(19). Studies that have investigated the
prevalence of metabolic syndrome among high-risk eth-
nic groups have identiﬁed that the diagnostic criteria
fail to detect T2D risk in populations of black African
ancestry(20–23). Looking in more detail, several interesting
differences from other ethnic groups have been described,
and a distinct metabolic phenotype is emerging.
Consistently, black African-Caribbean populations
have been reported to exhibit pronounced insulin resist-
ance(24–27) and higher rates of hypertension compared
to other ethnic groups(28,29) but in the absence of abdom-
inal obesity(25,30–32) and the characteristic dyslipidaemia
of the metabolic syndrome(26,30,33). Raised fasting TAG
and low HDL-cholesterol concentrations are the princi-
pal lipid abnormalities associated with insulin resistance
and T2D and are included in the diagnostic criteria for
the metabolic syndrome. Often the TAG:HDL ratio is
used as a lipid metric to detect T2D risk but there is
extensive evidence to show that it fails to detect risk in
populations of black African-Caribbean ethnicity(20–23).
These ﬁndings from large epidemiological studies have
provided evidence to suggest there are ethnic distinctions
in the pathophysiology of T2D among black
African-Caribbean ethnic groups, which have been inves-
tigated in detail in recent years.
Pathophysiology of type 2 diabetes
The main processes underlying the development of T2D
are well described and emphasise the role of obesity, vis-
ceral and ectopic fat accumulation, insulin resistance and
insulin secretory failure(34). Originally insulin resistance
was proposed as the primary abnormality(18) but earlier
defects within adipose tissue are now believed to trigger
a cascade of metabolic abnormalities, involving the
liver, skeletal muscle and pancreas(35). Three separate,
but not mutually exclusive, theories explain how dysfunc-
tional adipose tissue, and its inability to buffer excess fat,
is proposed to be a primary defect underlying the
L. M. Goff et al.2
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development of T2D (Fig. 2). The spillover theory pro-
poses that it is a limited capacity of subcutaneous adipo-
cytes to store fatty acids which results in an overﬂow of
fatty acids to the visceral compartment and expansion
of this depot(36). The portal theory proposes that hyper-
trophic dysfunctional visceral adipocytes are highly lipo-
lytic and have a greater ﬂux of fatty acids than
subcutaneous adipocytes, which are released into the
portal circulation and become deposited in the liver,
leading to ectopic fat accumulation in the liver and hep-
atic insulin resistance(37). The twin-cycle hypothesis pro-
poses that increased hepatic fat accumulation leads to
increased export of VLDL-TAG from the liver, which
then deposits in other organs and tissues, particularly
Fig. 1. Age distribution of people with type 2 diabetes in White-European, African-Caribbean
and South Asian ethnic groups in the UK. Reproduced from Paul SK et al.(6).
Fig. 2. Role of adipose tissue dysfunction and ectopic fat accumulation in the pathogenesis of type 2 diabetes. The spillover theory
proposes that it is a limited capacity of subcutaneous adipocytes to store fatty acids which results in an overﬂow of fatty acids to the
visceral compartment and expansion of this depot. The portal theory proposes that hypertrophic dysfunctional visceral adipocytes
are highly lipolytic and have a greater ﬂux of fatty acids, which are released into the portal circulation and become deposited in the
liver, leading to ectopic fat accumulation in the liver and hepatic insulin resistance. The twin-cycle hypothesis proposes that
increased hepatic fat accumulation leads to increased export of VLDL-TAG from the liver, which then deposits in other organs and
tissues, particularly the pancreatic β-cells, leading to the β-cell failure that underlies the development of type 2 diabetes.
Type 2 diabetes and black African ethnicity 3
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the pancreatic β-cells, leading to the β-cell failure that
underlies the development of frank T2D(38). It is the
accumulation of TAG within these ectopic depots that
is believed to play an integral role in the development
of T2D by causing metabolic disturbances within the
organs/tissues in which it resides, termed lipotoxicity.
Ectopic depots of importance include intrahepatic lipid
(IHL), intramyocellular lipid and intrapancreatic lipid
(IPL). In response to hepatic and peripheral insulin
resistance, compensatory hypersecretion of insulin ensues
to maintain normoglycaemia. Eventually ‘β-cell exhaus-
tion’ or ‘burn-out’ occurs whereby the β-cells are unable
to secrete sufﬁcient insulin and a hyperglycaemic state
develops(35). Heterogeneity in the relationship between
insulin sensitivity and insulin secretion has been recog-
nised whereby glucose tolerance can be maintained,
even in the presence of severe insulin resistance, if the
insulin secretory capacity of the β-cells is able to balance
the degree of insulin resistance. Conversely, an individual
can become hyperglycaemic with a relatively low level of
insulin resistance if they possess a relatively low β-cell
secretory capacity(39).
Ethnic distinctions in type 2 diabetes pathophysiology: a
focus on black African-Caribbean populations
Insulin resistance
The role of insulin resistance in the development of T2D
in black African-Caribbean populations has been in-
vestigated in many studies. Large cohort studies have
consistently reported exaggerated insulin resistance
among black African-Caribbean populations(26,30). The
ﬁrst of these was the insulin resistance atherosclerosis
study(24,25), which was conducted in America in the
1990s. A limitation of these epidemiological studies is
their use of indirect methods for assessing insulin sensi-
tivity, such as the homeostatic model assessment(40) and
the intravenous glucose tolerance test, which provide
just an estimate of insulin sensitivity, and only measure
at a whole-body level. The euglycaemic–hyperinsulinae-
mic clamp is considered the gold standard method for
assessing insulin sensitivity(41), which, when used with
the addition of stable isotopes, enables speciﬁc measure-
ment of hepatic and skeletal muscle insulin sensitivity,
thus providing greater insight as to where the defects in
insulin action are occurring. There have been several
studies investigating in vivo tissue-speciﬁc insulin resist-
ance using the euglycaemic–hyperinsulinaemic clamp
method with isotopes in black and white communities.
These studies have primarily focused on women and
high-risk adolescents, e.g. those with morbid obesity or
prediabetes. In adolescents, peripheral insulin sensitivity
has been shown to be lower(42–44) or no different(45–47)
in black compared to white populations with no clear
reasoning as to why they are different. In terms of hepatic
insulin sensitivity, black populations show no differ-
ence(42–45,48–51) or greater sensitivity(46) compared to
white adolescents. The greater hepatic insulin sensitivity
in black adolescents is acknowledged as a surprise to
the authors who believe it may be explained by lower
visceral adipose tissue (VAT). Studies in women assessing
peripheral insulin sensitivity show either no ethnic differ-
ences(52) or reduced sensitivity(53) in black compared to
white populations. The differences here are likely due
to the choice of female adiposity status (obese v. lean par-
ticipants, respectively). Studies in women, which have
assessed hepatic insulin sensitivity, show no differ-
ence(53,54), greater(52) or lower(55) sensitivity in black
compared to white populations. The inconsistences here
are likely due to methodological differences, where hep-
atic insulin resistance has been measured either at basal
or during a hyperinsulinaemic state, or the obesity status
of the participant populations. The very limited mixed
sex studies have revealed no ethnic differences in periph-
eral(56,57) or hepatic(56) insulin sensitivity in black com-
pared to white populations. Within black populations,
women have been shown to display lower insulin sensitiv-
ity in comparison to men(58,59). They also present with a
different body composition which suggests a sex-speciﬁc
pathophysiology may be present. Overall these inconsist-
ent ﬁndings could imply that the methods to assess insu-
lin sensitivity are affected by ethnicity or that insulin
resistance is not the sole driver for the increased T2D
risk in black populations.
Insulin secretory function
Unlike the assessment of insulin sensitivity, there is no
widely accepted gold standard methodology for the
determination of insulin secretory function; therefore,
the exploration of ethnic differences in this area has
been complicated by the wide variety of techniques
used. The most common techniques measure the insulin
response to stimulation of the β-cell by glucose, either
intravenously (as in the case of the hyperglycaemic
clamp or intravenous tolerance test) or orally (as in the
case of the oral glucose tolerance test or the mixed
meal tolerance test). Surrogate indices are also used,
which may be derived from fasting glucose and insulin,
such as homeostasis model assessments of β-cell func-
tion(40), or from the oral glucose tolerance test or
mixed meal tolerance test, such as the insulinogenic
index. Each method has its strengths and limitations,
for example, oral glucose and mixed meal tests are highly
physiological while intravenous techniques allow speciﬁc
assessment of the β-cell by excluding the modulating
effect of the incretin hormones(60,61). Most of the studies
in the literature have employed the intravenous glucose
tolerance test in their measurement of insulin secretion.
A recent review of these studies concluded that black
African-Caribbeans exhibit a higher insulin response to
glucose compared to white Europeans(62). This has
been demonstrated in studies in black populations both
in African countries(63,64) and across the globe(24,33,65).
Furthermore, this higher insulinaemic response can be
demonstrated from early childhood(66–68).
In a widely accepted paradigm of T2D, increased insu-
lin secretion represents a compensation for insulin resist-
ance in order to maintain normoglycaemia. Therefore, it
is important to note that when studies make an adjust-
ment for the prevailing insulin sensitivity of black
L. M. Goff et al.4
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populations (e.g. through the calculation of a disposition
index(69)), their insulin response to glucose remains
greater than that of white Europeans, suggesting that
the phenomenon is not simply a compensatory response
to increased insulin resistance(44,45,70,71). It has therefore
been speculated that β-cell function may be upregulated
in black populations, contributing to their increased
risk of T2D by predisposing to early β-cell exhaustion(45).
Hepatic insulin clearance
Circulating concentrations of insulin are determined by a
balance between the rate of insulin secretion from the
pancreatic β-cells and insulin degradation, which occurs
predominantly in the liver. Upon its secretion from pan-
creatic β-cells, insulin reaches the liver through the portal
circulation. Approximately 80 % of endogenous insulin is
cleared by the liver during the ﬁrst portal passage prior to
reaching the systemic circulation. While the liver is the
primary site of insulin clearance, the kidneys and skeletal
muscle are also involved in its degradation(72). To quan-
tify and differentiate the processes of insulin secretory
function and hepatic insulin clearance, it is necessary to
measure both c-peptide and insulin. C-peptide is
co-secreted with insulin in equimolar concentrations
but undergoes negligible metabolism in the liver; there-
fore, the measurement of circulating c-peptide provides
a true assessment of the rate of insulin secretion(73).
Looking at all the studies of β-cell function, it is import-
ant to note that only a small minority include the meas-
urement of c-peptide and are therefore able to
differentiate between insulin secretory function and hep-
atic insulin clearance. There is increasing evidence that
the hyperinsulinaemic response to glucose in black sub-
jects is due to ethnic differences in rates of insulin clear-
ance as well as β-cell insulin secretion. These studies have
consistently observed lower rates of insulin clearance in
black subjects compared to white(44,68,74). Furthermore,
recent advances in modelling techniques have demon-
strated that this is due to differences in hepatic rather
than extra-hepatic insulin clearance(75) and that reduced
hepatic insulin clearance in black subjects can also be
demonstrated from early childhood(76).
Visceral and ectopic fat deposition
The observation that abdominal/visceral fat is a more
sensitive predictor of insulin sensitivity than BMI has
led to considerable interest in visceral fat in black popu-
lations. These studies have recognised that, despite being
at high risk of T2D, black populations exhibit signiﬁ-
cantly less visceral fat than other ethnic groups(77), a phe-
nomenon that has been coined the African paradox. In a
large pooled analysis of black women, Sumner et al.
demonstrated a lesser increase in visceral fat per unit
increase in waist circumference in black compared to
white women(78), raising a question regarding the role
and importance of visceral fat in the development of
T2D in black populations(79).
Ectopic fat, deﬁned as the deposition of TAG within
cells of non-adipose tissue, is proposed to be central to
the development of T2D by causing metabolic
disturbances in the organs/tissues in which it resides(80).
Ectopic fat accumulation typically occurs during increas-
ing adiposity due to reduced expandability of adipocytes
within subcutaneous adipose tissue (SAT), which leads to
a spillover of NEFA into other organs(81). However, indi-
viduals who have lipodystrophies, where genetic factors
result in an inability to adequately store fat in SAT
depots, also have high ectopic fat accumulation and
develop insulin resistance at severely low BMI levels(82).
Therefore, an increase in ectopic fat is also considered
to be a marker of a metabolic state of overwhelmed dys-
functional SAT caused by its limited expandability. This
state is characterised by several features of SAT including
hypertrophic adipocyte expansion, increased inﬁltration
of macrophages, reduced insulin sensitivity and increased
release of inﬂammatory cytokines, which are an indicator
of chronic low-grade inﬂammation of SAT(83). The
degree of expandability of SAT, which determines the
point at which it dysfunctions, is mostly inﬂuenced by
intrinsic factors, such as sex, as women have a greater
capacity to store SAT leading to lower ectopic fat storage
and a lower risk of T2D(84). Recent research in South
Asians has indicated that ethnicity may also inﬂuence
the genetic factors that determine SAT expandability
and ectopic fat storage(85).
Ectopic fat has been studied in ethnic minority groups
to understand the impact of ethnicity on ectopic fat
deposition and its role in the development of T2D.
South Asian populations exhibit greater levels of VAT
and IHL at similar levels of whole-body adiposity com-
pared to white populations(86,87). This has commonly
been used to explain the greater risk of T2D in South
Asians since they have a reduced capacity to store excess
energy in SAT leading to increased ectopic fat depos-
ition(88). However, the same cannot be said for black
populations who, despite being at greater risk of T2D,
have lower levels of ectopic fat compared to their white
counterparts(79,89). This phenomenon has previously
been coined the African ectopic fat paradox(90).
The advancement of imaging technologies, such as
computerised tomography and MRI, has allowed the dir-
ect quantiﬁcation of regional fat deposition. Thereafter,
several studies have reported ethnic differences in
regional fat deposition between black and white popula-
tions. From as early as the 1990s, several studies have
reported lower levels of VAT in black populations com-
pared to white populations which has become a well-
accepted phenomenon(79,89). Furthermore, with increas-
ing whole-body adiposity, VAT has been shown to
increase to a lesser extent in blacks compared to whites,
indicating a greater capacity to store excess energy in the
more favourable SAT depot in blacks(91).
While the pathogenic potential of VAT is well
accepted in T2D risk, several reports have shown that
the accumulation of IHL is more detrimental and plays
a greater role in the development of T2D(92–94).
Similarly to VAT, IHL has also been reported to be con-
sistently lower in black compared to white popula-
tions(95,96). Furthermore, several large cohort studies
have shown that the prevalence of non-alcoholic fatty
liver disease is considerably lower in black populations
Type 2 diabetes and black African ethnicity 5
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
https://doi.org/10.1017/S0029665119001034
Downloaded from https://www.cambridge.org/core. King's College London, on 31 Jul 2019 at 08:09:49, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
and, in some studies, the prevalence is half that of white
populations(97,98). Lower levels of IHL, along with more
favourable lipid proﬁles and reduced metabolic distur-
bances of the liver, have led researchers to question the
understanding of the role of metabolic disturbances of
the liver in the development of T2D in black
populations(54,99).
Unlike VAT and IHL, there has been less investigation
of IPL and intramyocellular lipid in black populations,
which may be due to limitations in the techniques used
to determine these depots, or the lack of clarity regarding
their role in the development of T2D. Current investiga-
tions show that while intramyocellular lipid does not
appear to differ between black and white populations,
it is inversely associated with insulin sensitivity in white
populations but not black populations, which may indi-
cate a lesser role for intramyocellular lipid in insulin
resistance in black individuals(100,101). Investigations of
IPL in black populations provide inconclusive ﬁndings;
while IPL appears lower in black populations compared
to whites(102,103), some reports ﬁnd it to be inversely asso-
ciated with β-cell insulin secretory function in blacks(102),
while others report no such association(103). In a study
investigating the role of IHL and IPL in blacks,
Toledo-corral et al. showed IPL predicted prediabetes
status in blacks while IHL did not, indicating IPL may
be more detrimental than IHL in black populations(104).
The South London Diabetes and Ethnicity Phenotyping
study
The South London Diabetes and Ethnicity Phenotyping
(SouL-DeEP) study is being conducted to provide a
detailed comparison of the principal pathophysiological
processes involved in the development of T2D between
men of black west African and white European ethnicity,
to test the hypothesis that T2D is driven by relatively
early failure of β-cell insulin secretory function in black
west African men. Highly sophisticated techniques are
being used: hyperglycaemic clamp and meal tolerance
test methods enable the assessment of β-cell function,
hepatic insulin clearance and incretin secretion; the
euglycaemic–hyperinsulinaemic clamp with stable iso-
tope infusions enables the assessment of insulin sensitiv-
ity at a whole-body level as well as distinguishing hepatic,
skeletal muscle, and adipose tissue insulin sensitivity; and
MRI and spectroscopy methods are being used to assess
visceral fat and ectopic fat deposition in the skeletal mus-
cle, liver and pancreas. Our study focuses on men as there
is consistent evidence for sex differences in T2D patho-
physiology in populations of black African ances-
try(105,106). While the development of T2D in black
women has been reasonably well studied(52,64,107), there
is a relative lack of studies conducted in men, despite
high rates of T2D, which we aim to address through
our work.
In our study of men with T2D, we have demonstrated
greater insulin secretory deﬁcits in black west African
men compared with white Europeans(108). Moreover,
we have recognised that black west African men exhibit
a comparable circulating insulin concentration to that
of white Europeans through a greater reduction in hep-
atic insulin clearance, which acts to preserve circulating
insulin concentrations(108). Importantly, we have recog-
nised that these ethnic differences in β-cell function and
hepatic insulin clearance are not in response to differ-
ences in insulin sensitivity, as our clamp methods demon-
strate comparable whole body, hepatic and peripheral
insulin sensitivity(109,110).
Our imaging methods have enabled us to quantify vis-
ceral, liver and pancreatic fat and to investigate the asso-
ciations between these measures and the metabolic
processes. The black west African men have been
found to have signiﬁcantly lower visceral, hepatic and
pancreatic fat compared to the white European
men(111–114), yet they exhibit comparable insulin resist-
ance(110) and greater β-cell failure(108). We have investi-
gated whether there are ethnic differences in the
associations between the fat depots and the meta-
bolic variables and have found that whilst visceral fat
associates with insulin resistance in both ethnic
groups(109,110), hepatic fat associates with hepatic insulin
resistance in only the white European men(113) but associ-
ates with hepatic insulin clearance in only the black west
African men(113). Pancreatic fat has been found to asso-
ciate with β-cell function but only in the white
European men(114). These ﬁndings, taken together,
show clear evidence of ethnic distinctions in the patho-
physiology of T2D.
Our ﬁndings challenge the relevance of existing theor-
ies that put ectopic fat at the centre of the pathophysi-
ology of T2D (Fig. 2), to populations of black
African-Caribbean ethnicity. We have shown lower vis-
ceral and hepatic fat in black west African men, yet com-
parable insulin sensitivity; furthermore, the association
between hepatic fat and insulin resistance that was seen
in white European men was not evident in black west
African men. Pancreatic fat is believed to be a principal
driver of β-cell failure, according to the twin cycle
hypothesis(38), yet β-cell function was associated with
pancreatic fat only in our white European men. These
ﬁndings lead us to hypothesise that insulin resistance
and β-cell failure develop independently of ectopic fat
accumulation in black west African populations, and
that ectopic fat is not the primary defect underlying the
development of T2D. We are currently extending our
work to investigate these mechanisms in men who are
normally glucose tolerant and in men with impaired glu-
cose tolerance to provide a greater understanding of how
they are implicated in the progression to T2D. Data from
our normal glucose-tolerant participants show that black
men exhibit a pronounced hyperinsulinaemia compared
to white men, and that this is driven by signiﬁcantly
lower hepatic insulin clearance rates rather than upregu-
lated insulin secretion(115). This leads us to hypothesise
that hyperinsulinaemia is a primary defect in black
west African men that occurs as a result of lower rates
of hepatic insulin clearance, rather than in response to
relative reductions in insulin sensitivity. We await further
data on ectopic fat deposition and tissue-speciﬁc insulin
sensitivity in our cohort of healthy men and in the men
with impaired glucose tolerance, which will enable us
L. M. Goff et al.6
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to shed further light on our hypothesis and a much
greater understanding of ethnic distinctions in the patho-
physiology of T2D.
Conclusions
Populations of black African-Caribbean ethnicity are
disproportionately affected by T2D. While the main-
stream understanding of T2D pathophysiology focuses
on the role of visceral and ectopic fat accumulation lead-
ing to insulin resistance and insulin secretory failure,
there is compelling evidence for distinct processes in
black populations. In populations of black African-
Caribbean ethnicity, there is less central obesity and
absence of the dyslipidaemia associated with insulin
resistance. Furthermore, the metabolic syndrome criteria
have little clinical utility for recognising T2D risk in
black populations. More detailed investigations, showing
lower VAT and hepatic fat deposition in black popula-
tions, provide evidence to suggest that ectopic fat plays
a less central role in the development of insulin resistance
in black populations. Hyperinsulinaemia is present, even
in a healthy, normal glucose-tolerant state, driven by
lower rates of hepatic insulin clearance rather than upre-
gulated insulin secretion, and may be a primary defect in
black populations. A greater understanding of these pro-
cesses and the mechanisms underlying the development
of T2D in black populations may lead to much needed
improvements in prevention and treatment strategies.
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